Allogene Therapeutics Inc (NAS:ALLO)
$ 2.075 -0.005 (-0.24%) Market Cap: 433.23 Mil Enterprise Value: 138.33 Mil PE Ratio: 0 PB Ratio: 0.77 GF Score: 28/100

Q4 2023 Allogene Therapeutics Inc Earnings Call Transcript

Mar 14, 2024 / 09:00PM GMT
Release Date Price: $4.5 (-7.89%)
Operator

Thank you for standing by, and welcome to Allogene Therapeutics Fourth Quarter and Full Year 2023 conference call. (Operator Instructions) Please be aware that today's call is being recorded. I'd now like to turn the call over to Christine Cassiano, Chief Corporate Affairs and Brand Strategy Officer. Ms. Cassiano, please go ahead.

Christine Cassiano
Allogene Therapeutics Inc - EVP, Chief Corporate Affairs and Brand Strategy Officer

Thank you, operator, and welcome to offer and showing a call after the market closed today, Allogene issued a press release that provides a business update and financial results for the fourth quarter and full year 2023. This press release and today's webcast are available on our website. Following our prepared remarks, we will host a Q&A session. We ask you to limit your questions to one per person as we will keep this call to an hour and do our best to get to as many questions as possible. Joining me today are Dr. David Chang, President and Chief Executive Officer; Dr. Zachary Roberts, Executive Vice President of Research and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot